Insulin model

It is clear, therefore, that core-box models with the additional characteristics of Eq. (11) (such as the insulin model in Section 5.3) have major potential in the future developments of hierarchical models describing larger systems. In this way, the potential drug targets predicted by the core-box model may be judged, not only by their quality tag, but also through their translated importance on the whole-body behavior. Both of these possibilities are very important to achieve the full potential of biosimulation of potential dmg targets. 

There are numerous articles on glucose-insulin modeling owing to its relevance for patients with diabetes mellitus. Diabetes is a chronic syndrome, characterized by insufficient insulin production in the pancreas or decreased insulin activity, resulting in increased blood... 

Bradykinin stimulates natriuresis and, through stimulation of prostaglandin synthesis, inhibits the actions of antidiuretic hormone (ADH), thereby inhibiting water retention. Bradykinin further improves insulin sensitivity and cellular glucose utilization of skeletal muscle cells in experimental models. This, however, appears not to be relevant in the clinical context. 

Thiazolidinediones (PPARy-agonists) Thiazolidine-diones ( pioglitazone, rosiglitazone) lower blood glucose levels in animal models of insulin resistance and also in insulin resistant patients. They are agonists of the peroxisome proliferator-activated receptor y (PPARy). Because they enhance the effect of insulin and reduce serum insulin levels in insulin resistant patients, thiazolidinediones are usually referred to as insulin sensitizers . 

Knockout mice have been reported for several FATPs [1]. As insulin desensitization has been closely linked to excessive fatty acid uptake and intracellular diacylgly-cerol and TG accumulation, these animal models were particularly evaluated in the context of protection from diet-induced type 2 diabetes ( Type 2 Diabetes Mellitus (T2DM)). In addition, studies on human subjects have also established genetic links between polymorphisms in FATP genes and metabolic alterations [1]. 

Thiazolidinediones (synonyms glitazones, insulin sensitizers rosiglitazone, pioglitazone) are a novel class of oral antidiabetic drugs that activate the transcription factor peroxisome proliferator-activated receptor (PPARy). Thiazolidinediones ameliorate insulin resistance in obese animal models and in individuals... 

Other Formulations. Neural networks have been applied to the modeling of pellet formulations to control the release of theophylline [63] and to control the rate of degradation of omeprazole [64]. They have also been applied to the preparation of acrylic microspheres [65] and to model the release of insulin from an implant [66]. In arecent study from Brazil, the release of hydrocortisone from a biodegradable matrix has been successfully modeled [67]. 

HPLC reverse phase procedures were established to follow the continuous release rates of a variety of agents from the two resins. Also a USP standard release test procedure (8) was used. Because of its ease of detection at the higher ultraviolet wave lengths, bovine insulin was used as the model delivery agent... 

One-to-one random copolymers of acrylic acid with either hydroxyethyl acrylate (a hydrogel model) or methyl acrylate failed to protect insulin from release under gastric conditions (Figure 6). In the case of the hydrogel, the expected swelling due to exposure to water occurred, releasing insulin. The behavior of the ester copolymer led to the prediction that there should be no more than about four carbon atoms per carboxylic acid group in a repeat unit of the polymers. We have not been able to disprove this hypothesis thus far. 

Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 1997 272 22330-22339. 

Theoretical and model analysis based on a nanofluidic approach is needed for this situation. One may ask, is it possible to release proteins loaded in nanotubules We have found that the addition of the polycation PEI in the release solvent resulted in much quicker protein release, as demonstrated in Figure 14.9. In this case, most of the insulin was released in 1 hour instead of 100 hours. 10-40% of glucose oxidase, catalyse, and hemoglobin were released within 4 hours through complexation with PEI. It is unclear, whether the proteins were replaced by the polycation or released in a complex with PEI. 

D. Schmidtke, A. Freeland, A. Heller, and R. Bonnecaze, Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc. Natl. Acad. Sci. U.S.A. 95, 294-299 (1998). 

Proteins may be stabilized by encapsulation in polyanhydride microspheres. Stability of proteins with respect to water-induced aggregation has been demonstrated to be a function of polymer hydrophobicity for insulin and bovine somatotropin as model proteins (Ron et al., 1993). Encapsulation and enzymatic activity of a variety of other proteins encapsulated in P(SA FAD) was studied by Tabata et al. (1993). 

It should be mentioned that the inhibition of superoxide overproduction and lipid peroxidation by lipoic acid has been recently shown in animal models of diabetes mellitus. The administration of LA to streptozotocin-diabetic rats suppressed the formation of lipid peroxidation products [213], In another study the supplementation of glucose-fed rats with lipoic acid suppressed aorta superoxide overproduction as well as an increase in blood pressure and insulin resistance [214]. 

---